HSBC Holdings
WVE icon

HSBC Holdings’s Wave Life Sciences WVE Stock Holding History

HSBC Holdings’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
+370,449
New +$2.46M ﹤0.01% 1560
2026
Q1 		– Sell
-16,990
Closed -$291K – 3266
2025
Q4 		$291K Buy
16,990
+5,823
+52% +$59.2K ﹤0.01% 2541
2025
Q3 		$81.7K Buy
+11,167
New +$90.3K ﹤0.01% 2613
2025
Q2 		– Sell
-11,158
Closed -$89.5K – 3266
2025
Q1 		$89.5K Buy
11,158
+437
+4% +$4.78K ﹤0.01% 2828
2024
Q4 		$132K Sell
10,721
-3,565
-25% -$47.6K ﹤0.01% 2829
2024
Q3 		$119K Sell
14,286
-7,158
-33% -$42.8K ﹤0.01% 2766
2024
Q2 		$104K Buy
+21,444
New +$122K ﹤0.01% 2720

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.58% 1-Year Est. Return

HSBC Holdings's WVE Position: Q2 2026 in Review

HSBC Holdings opened a new position in Wave Life Sciences (WVE) in Q2 2026: 370,449 shares worth $2.17M. The stake represents ﹤0.01% of the portfolio and ranks #1560 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in WVE as recently as Q4 2025.

HSBC Holdings first reported a position in WVE in Q2 2024 and has held it in 7 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • HSBC Holdings held 370,449 shares of Wave Life Sciences worth $2.17M as of Q2 2026.
  • Wave Life Sciences was a new HSBC Holdings position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1560 holding.
  • HSBC Holdings first reported a position in Wave Life Sciences in Q2 2024 and has held it in 7 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.